H.L. Nisenbaum

Discipline

Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Co-auteur

D.A. Torigian

D.J. Powell

R. Mick

L.E. Kandalaft

G. Coukos

C.L. Chiang

E. Zsiros

S. Tissot

A.C. Thierry

D. Tarussio

J.L. Tanyi

B.J. Stevenson

A.L. Huguenin-Bergenat

F. Huber

A. Harari

H.F. Guiren

C. Goepfert

J. Chiffelle

P. Baumgartener

M. Bassani-Sternberg

R. Ahmed

J. Tanyi

N. Svoronos

L. Smith

G.T. Motz

K. Montone

G.M. Mantia-Smaldone

B.L. Levine

M. Kalos

A.R. Hagemann

B.J. Czerniecki

Date

Source

Serveur académique Lausannois (3)

Mot-clé

cancer (3) Cancer (3) T cells (3) Cancer (3) survie (2) Survival (2) Strategy (2) Cells (2) thérapie (1) sécurité (1) traitement (1) oxydation (1) nécrose (1) modèle (1) acide (1) irradiation (1) immunité (1) méthode (1) procès (1) abords (agglomération) (1) Development (1) Treatment (1) Oxidation (1) Showing (1) Methods (1) Chemokines (1) Apoptosis (1) Antigenic determinants (1) Tumors--Growth (1) Value (1)

Documents écrit par H.L. Nisenbaum (3) | parle de H.L. Nisenbaum (0)

Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.

J.L. Tanyi et al. (4 mai 2021)

Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.

J.L. Tanyi et al. (15 mars 2021)

A dendritic cell vaccine pulsed with autologous hypochlorous Acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside.

C.L. Chiang et al. (2013)